Charles River’s lifelong CDMO leader

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Kerstin Dolph, Senior Vice President of Manufacturing at Charles River Laboratories.

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Kerstin, covering:

• The value of having managers and mentors guide you and champion your success
• Navigating transitions from finance to operations and research to biologics manufacturing while becoming a senior leader at CRL
• Tackling the task of integrating testing and manufacturing at CRL globally to cut timelines for clients
• The importance of staying close and connected to the patient so you never lose sight of the impact of the work done in this space
• Stabilizing signs in the biotech market and pivoting to the market’s needs in creative ways

Kerstin joined Charles River in 2001 in a Finance role for the Company’s Research Models and Services (RMS) business in Germany. She transitioned to the U.S. RMS business in 2009 and was promoted to Senior Finance Director of Global RMS in 2015. In 2017, Ms Dolph was promoted to Corporate Vice President of North American RMS, responsible for leading the Company’s North American RMS business. This included managing several consolidation and efficiency initiatives and global RMS technology enhancements.

In 2019, Ms Dolph assumed the role of Corporate Vice President of Global Biologics. Subsequently, she assumed responsibility for the Company’s CDMO business and was promoted to senior vice president of biologics solutions in October 2021. Ms. Dolph is currently the Senior Vice President of Manufacturing. She is responsible for driving each business’s strategic direction and future growth within the Company’s Manufacturing Solutions segment, including Biologics Testing Solutions, CDMO, and Microbial Solutions.

Ms. Dolph holds a bachelor’s degree from the International Accountancy & Business School in Wuerzburg, Germany and was recognised by the Bavarian Government for outstanding performance.

This episode of Molecule to Market is sponsored by Vetter, a global leader in aseptic filling solutions for injectable products in the pharmaceutical and biotech industries. Discover more about Vetter’s comprehensive services, from early-stage development to commercial production, and how they support clients in delivering high-quality therapies to the market.

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

Molecule to Market is sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.